Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L5 pseudogene 1 (RPL5P1) is a processed pseudogene that arose from retrotransposition of the RPL5 mRNA. It does not encode a functional protein and is scattered in the genome alongside many other ribosomal protein pseudogenes. Pseudogenes like RPL5P1 are commonly found throughout the human genome and may share high sequence similarity to their parent gene but generally lack biological function and are not considered druggable targets or disease modulators. In contrast, the parent gene RPL5 encodes a critical ribosomal protein involved in ribosome biogenesis and has clinical significance in rare syndromes and some cancers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L5 pseudogene 1 (RPL5P1).